William G. Rice insider trades
Open-market stock purchases and sales by William G. Rice, Chair, President & CEO at Aptose Biosciences Inc, from SEC Form 4 filings since Jan 2, 2019.
Track record: 40% of 10 scored buys are up 5% or more since purchase, averaging +12%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 30, 2026 | APTO Aptose Biosciences Inc | Sold (not open market) | $1.1M |
| Jun 30, 2026 | APTO Aptose Biosciences Inc | Sold (not open market) | — |
| Jun 30, 2026 | APTO Aptose Biosciences Inc | Sold (not open market) | — |
| Jun 30, 2026 | APTO Aptose Biosciences Inc | Sold (not open market) | — |
| Jun 30, 2026 | APTO Aptose Biosciences Inc | Sold (not open market) | — |
| Jun 30, 2026 | APTO Aptose Biosciences Inc | Sold (not open market) | — |
| Jun 30, 2026 | APTO Aptose Biosciences Inc | Sold (not open market) | — |
| Jun 30, 2026 | APTO Aptose Biosciences Inc | Sold (not open market) | — |
| Jun 30, 2026 | APTO Aptose Biosciences Inc | Sold (not open market) | — |
| Jun 30, 2026 | APTO Aptose Biosciences Inc | Sold (not open market) | — |
Companies traded
- APTO Aptose Biosciences Inc: 12 buys, 1 sale, last Jun 30, 2026